openPR Logo
Press release

Mental Disorders Drugs Market Research Report by Regional Analysis with forecast upto 2024

03-07-2017 06:39 PM CET | Health & Medicine

Press release from: Transparency Market Research - Pharmaceutical

Mental Disorders Drugs Market Research Report by Regional

Global Mental Disorders Drugs Market: Overview

A mental disorder can be explained as a psychological anomaly that is reflected in patient’s behavior through disability, distress, or any conduct that is not considered as normal mental development. The causes of mental disorders are very diverse and often unclear in most cases. However, some of the commonly addressed drug classes for the treatment of mental disorders are anxiolytics, antidepressants, and antipsychotics. Some of the common mental disorders affecting millions around the world are depression, schizophrenia, and intellectual disabilities and disorders due to drug abuse.

The most common factor aiding the expansion of the global mental disorders drugs market is the rising incidence of mental disorders. For instance, as per the WHO’s reviewed fact sheet, as of 2016 over 350 million people worldwide are affected by depression, over 60 million people are diagnosed with bipolar disorder, and almost 21 million people around the world have schizophrenia and other psychoses. The incidence is rising and there is less likely for it to subside anytime soon. Governments around the world are thus focusing on development effective treatment and drugs to eliminate the prevalence of mental disorders.

Considering the scenario, the global mental disorders market is poised to surge at an exponential pace between 2016 and 2024. In the report, TMR provides a granular analysis of the various factors supporting the market’s growth and lists down the restraints threatening its expansion. Using Porter’s five forces, the report gauges the bargaining power of suppliers and buyers, degree of competition prevailing in the market, and threat of product substitutes and new entrants. The effect of government policies on the market is analyzed in detail.

Besides these, the report also studies the regional market for mental disorders drugs across North America, Europe, Asia Pacific, and Rest of the World. Factors influencing the market’s growth across these regional segments are studied in detail. In addition, the global mental disorders drugs market has been segmented based on various parameters to help the market participants identify the most lucrative areas in the market. Compiled with exhaustive information, the report thus provides a holistic overview of the global mental disorders market.

Browse full report on Mental Disorders Drugs Market -
http://www.transparencymarketresearch.com/mental-disorders-drugs.html

Global Mental Disorders Drugs Market: Trends and Opportunities

Factors such as improvement in patient security policies, increasing prevalence of mental disorders, growth in domestic and international investment in research and development on mental medication, and increasing awareness about these conditions are aiding the growth of the global mental disorders market.

Overall, the market has been witnessing lucrative prospects, however, skepticism surrounding the social pressure and stigma often attached with mental disorders and their treatment could restraint the market to an extent. The situation is more critical in case of less developed countries, where medical advancements are yet to penetrate into. Furthermore, inadequate government initiatives could create bottleneck for the market in underdeveloped countries, despite the high prevalence of unmet medical needs.

Nevertheless, rising government spending in the healthcare sector, especially across emerging economies such as India and China, increasing medical tourism in these nations due to the availability of advanced treatments at affordable price, and supportive reimbursement policies will help the expansion of mental disorders drugs market over the course of the forecast period. Besides this, the market is also expected to gain from the launch of novel therapeutics.

Overall, the global mental disorders drugs market can be segmented into antipsychotics, antidepressants, anxiolytics, drugs for adolescent and childhood mental illness, schizophrenia, drugs for the treatment of addiction, and bipolar disease drugs. The report studies in detail the recent developments supporting the market’s growth across these segments.

Global Mental Disorders Drugs Market: Regional Outlook

Regionally, North America dominates the global mental drugs disorders market. The increasing government initiatives, high awareness about mental disorders and available treatments, and better reimbursement policies are supporting growth of the market in North America. In addition, the market is expected to witness lucrative opportunities in Asia Pacific. The expanding healthcare industry and favorable initiatives supporting the growth will help market participants rake high profits in the region.

Global Mental Disorders Drugs Market: Vendor Landscape

The report includes a detailed assessment of the vendor landscape, to study the competition prevailing in the global mental disorders market. Some of the companies profiled are Johnson and Johnson, Pfizer, Eli Lilly, GlaxoSmithKline, AstraZeneca, and Bristol-Myers Squibb. Using SWOT analysis, the report studies the strengths and weaknesses of the companies profiled. The analysis also provides insights into the threats and opportunities that the companies will witness over the course of the forecast period.

Request for sample of this report -
http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=904

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR syndicated research report covers a different sector – such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.

US Office Contact

90 State Street, Suite 700

Albany, NY 12207

Tel: +1-518-618-1030

USA – Canada Toll Free: 866-552-3453

Email: sales@transparencymarketresearch.com

Website: http://www.transparencymarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Mental Disorders Drugs Market Research Report by Regional Analysis with forecast upto 2024 here

News-ID: 460751 • Views:

More Releases from Transparency Market Research - Pharmaceutical

Neurovascular Devices Market Business Opportunities and Growth Challenges Report
Neurovascular Devices Market Business Opportunities and Growth Challenges Report
Global Neurovascular Devices Market: Overview The global population is aging rapidly. According to WHO, the chances of health risks are greater in geriatric people than the young generation. Old age is considered to be one of the biggest risk factors that are responsible for developing various diseases such as cardiovascular and neurological conditions. It is because of these factors, the global neurovascular devices market is experiencing robust growth in the
Pneumococcal Vaccines Market anticipated expand at a CAGR of 3.3% from 2018 to 2026
Pneumococcal Vaccines Market anticipated expand at a CAGR of 3.3% from 2018 to 2 …
Transparency Market Research (TMR) has published a new report titled, “Pneumococcal Vaccines Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026”. According to the report, the global pneumococcal vaccines market was valued at US$ 7,247.6 Mn in 2017 and is anticipated expand at a CAGR of 3.3% from 2018 to 2026. Increase in patient pool, growth of the pharmaceutical industry, government initiatives to increase vaccination programs, rise
Swab and Viral Transport Medium Market projected to expand at a CAGR of ~3% from 2020 to 2030
Swab and Viral Transport Medium Market projected to expand at a CAGR of ~3% from …
Swab and Viral Transport Medium Market: Introduction Transparency Market Research has published a new report titled, ‘Global Swab and Viral Transport Medium Market ’. According to the report, the global swab and viral transport medium market was valued at US$ 0.9 Bn in 2019 and is projected to expand at a CAGR of ~3% from 2020 to 2030. Viral transport medium (VTM) enables safe transfer of viruses, chlamydia, and mycoplasma for
Radiofrequency Ablation Devices Market by Product, Geography and Forecast to 202 …
Transparency Market Research (TMR) has published a new report titled, 'Radiofrequency Ablation Devices for Pain Management Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019-2027'. According to the report, the global radiofrequency ablation devices for pain management market was valued at US$ 543.0 Mn in 2018 and is projected to expand at a CAGR of above 11.0% from 2019 to 2027. Overview Radiofrequency ablation is a minimally invasive surgical

All 5 Releases


More Releases for Mental

Synapse Mental Wellbeing: Personalized Mental Health Care for Individuals, Compa …
Bangalore, India - April 9th - Founded by Pranav Amarnath, Synapse Mental Wellbeing is a leading provider dedicated to fostering holistic well-being, with a significant emphasis on corporate wellbeing through tailored Employee Assistance Programs (EAPs) and Employee Wellbeing Programs (EWPs). Alongside these crucial workplace initiatives, Synapse offers accessible and personalized mental health care for individuals, couples, children, and organizations. Synapse Mental Wellbeing is committed to serving the community by providing a
Key Influencer in the Mental Health Market 2025: Rising Prevalence Of Mental Dis …
What industry-specific factors are fueling the growth of the mental health market? The rise in the occurrence of mental disorders is projected to fuel the expansion of the mental health market in the foreseeable future. These mental conditions are described as impairments that are clinically observable in an individual's cognitive function, emotional regulation, or behavior. They have a crucial role in mental health in terms of facilitating the identification of disorders,
Anima Launches Employee Mental Wellness Tracker to Revolutionize Workplace Menta …
Image: https://www.globalnewslines.com/uploads/2025/01/3b2917c69b737c950f874241fa685695.jpg Deloitte's "Mental Health and Employers" 2022 report estimates that the overall cost of poor mental health to UK employers in 2020-21 was $66.41 - $70.17 billion, primarily driven by absenteeism, presenteeism (working while unwell), and labor turnover. Alarmingly, nearly 40% of turnover costs now stem from mental health issues, underscoring the need for proactive interventions. Image: https://www.globalnewslines.com/uploads/2025/01/3688ec014a5e53547558325b34b4d7b6.jpg But there's good news: the return on investment (ROI) for mental health initiatives averages
Mental Health Software Market: Revolutionizing Mental Healthcare with Advanced D …
In recent years, the global Mental Health Software Market has witnessed a dynamic shift, influenced by changing consumer preferences, technological advancements, and a growing emphasis on sustainability. The Research report on Mental Health Software Market presents a complete judgment of the market through strategic insights on future trends, growth factors, supplier landscape, demand landscape, Y-o-Y growth rate, CAGR, pricing analysis. It also provides and a lot of business
10-08-2024 | Health & Medicine
Getnews
Veteran Mental Health Assessment (VMHA) Launches Mental Health Assessment Proces …
Image: https://www.getnews.info/wp-content/uploads/2024/10/1728348730.jpeg Dwayne Edwards, Founder & Chief Executive Officer of Veteran Mental Health Assessment Free consultation for veterans who deserve mental health benefits and need advocacy FRISCO, Texas - October 7, 2024 - Veteran Mental Health Assessment (VMHA) today announced that it has developed a mental health assessment process that enables U.S. veterans to receive the most appropriate benefits for their mental health conditions from the Veterans Administration (VA). VMHA's experienced psychologists
Emerging Mental Health Devices and Platforms Market Mental Wellness on Demand So …
Global Emerging Mental Health Devices and Platforms Market Size to Expand Lucratively and Reach USD 17.64 Billion to 2031 - Explained Details | Updated InsightAce Study InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Emerging Mental Health Devices and Platforms Market Size, Share & Trends Analysis Report By Products (Platforms and Devices), Therapies (Cognitive Behaviour Therapy (CBT), Electrotherapy, and Other Therapy), End-Users (Patients, Providers,